Alcyomics® to Transform Drug Discovery for Osteoarthritis Treatment With Unique In Vitro Bio-Printed 3D Tissue Model.
Newcastle upon Tyne, 26 January, 2023. Alcyomics Limited® announces it is seeking partners to participate in validation tests of its unique in vitro 3D bio-printed Osteoarthritis tissue model.Read more
What does the FDA modernisation Act 2.0 mean for pharmaceutical research?
Alcyomics cell therapy whitepaper
See how Alcyomics can help with cellular therapies.Read more
Understanding the downsides to animal testing
Animal testing has been, and largely continues to be, a gold standard to test both the efficacy and safety of new pharmaceuticals and therapeutics.Read more
July Blog 2022 - Immunotoxicity assessment criteria
Immunotoxicity assessment is a huge consideration when developing a new pharmaceutical intended for use in humans. Are 2D cell based systems enough to truly model immunotoxicity?Read more
JSIT poster sneak peak
Why not also join our mailing list so we can keep you updated with all our exciting news!Read more